Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11292782 Diarylhydantoin compounds and methods of use thereof

Patent 11292782 was granted and assigned to Nuvation Bio on April, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

The disclosure relates to anti-cancer compounds derived from nuclear steroid receptor binders, to products containing the same, as well as to methods of their use and preparation.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11292782 Diarylhydantoin compounds and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo